Report Detail
Global Pet Cancer Therapeutics Market Research Report 2019
- RnM3192053 |
- 26 March, 2019 |
- Global |
- 106 Pages |
- QYResearch |
- Pharma & Healthcare
Pet cancer therapeutics are the novel drug molecules that exhibit high potential to reduce the effects of cancer, giving access to comprehensive cancer care with minimum side effects. Cancer therapies aims to permanently eradicate the cancerous cells prevalent in pets. The veterinarian recommends specific treatment program such as targeted therapy and combination therapy or chemotherapy depending on the type of cancer, stage, and nature of the cancer.
The ongoing research activities undertaken by the scientists for the development of novel formulations and therapies is expected to accelerate the market growth.
The global Pet Cancer Therapeutics market is valued at 180 million US$ in 2018 is expected to reach 330 million US$ by the end of 2025, growing at a CAGR of 7.7% during 2019-2025.
This report focuses on Pet Cancer Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pet Cancer Therapeutics market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Aratana Therapeutics, Inc
AB Science
Boehringer Ingelheim International GmbH
Zenoaq
Morphogenesis, Inc
VetDC, Inc
Karyopharm Therapeutics, Inc
Rhizen Pharmaceutical SA
Regeneus Ltd.
Oasmia Pharmaceuticals AB
Zoetis
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Chemotherapy
Targeted Therapy
Combination Therapy
Immunotherapy
Segment by Application
Lymphoma
Mast Cell Cancer
Melanoma
Mammary
Squamous Cell Cancer
Others
Table of Contents
Executive Summary
1 Pet Cancer Therapeutics Market Overview
- 1.1 Product Overview and Scope of Pet Cancer Therapeutics
- 1.2 Pet Cancer Therapeutics Segment by Type
- 1.2.1 Global Pet Cancer Therapeutics Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 Chemotherapy
- 1.2.3 Targeted Therapy
- 1.2.4 Combination Therapy
- 1.2.5 Immunotherapy
- 1.3 Pet Cancer Therapeutics Segment by Application
- 1.3.1 Pet Cancer Therapeutics Consumption Comparison by Application (2014-2025)
- 1.3.2 Lymphoma
- 1.3.3 Mast Cell Cancer
- 1.3.4 Melanoma
- 1.3.5 Mammary
- 1.3.6 Squamous Cell Cancer
- 1.3.7 Others
- 1.4 Global Pet Cancer Therapeutics Market by Region
- 1.4.1 Global Pet Cancer Therapeutics Market Size Region
- 1.4.2 North America Status and Prospect (2014-2025)
- 1.4.3 Europe Status and Prospect (2014-2025)
- 1.4.4 China Status and Prospect (2014-2025)
- 1.4.5 Japan Status and Prospect (2014-2025)
- 1.5 Global Pet Cancer Therapeutics Market Size
- 1.5.1 Global Pet Cancer Therapeutics Revenue (2014-2025)
- 1.5.2 Global Pet Cancer Therapeutics Production (2014-2025)
2 Global Pet Cancer Therapeutics Market Competition by Manufacturers
- 2.1 Global Pet Cancer Therapeutics Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Pet Cancer Therapeutics Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Pet Cancer Therapeutics Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Pet Cancer Therapeutics Production Sites, Area Served, Product Types
- 2.5 Pet Cancer Therapeutics Market Competitive Situation and Trends
- 2.5.1 Pet Cancer Therapeutics Market Concentration Rate
- 2.5.2 Pet Cancer Therapeutics Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Pet Cancer Therapeutics Production Market Share by Regions
- 3.1 Global Pet Cancer Therapeutics Production Market Share by Regions
- 3.2 Global Pet Cancer Therapeutics Revenue Market Share by Regions (2014-2019)
- 3.3 Global Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Pet Cancer Therapeutics Production
- 3.4.1 North America Pet Cancer Therapeutics Production Growth Rate (2014-2019)
- 3.4.2 North America Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Pet Cancer Therapeutics Production
- 3.5.1 Europe Pet Cancer Therapeutics Production Growth Rate (2014-2019)
- 3.5.2 Europe Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Pet Cancer Therapeutics Production (2014-2019)
- 3.6.1 China Pet Cancer Therapeutics Production Growth Rate (2014-2019)
- 3.6.2 China Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Pet Cancer Therapeutics Production (2014-2019)
- 3.7.1 Japan Pet Cancer Therapeutics Production Growth Rate (2014-2019)
- 3.7.2 Japan Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Pet Cancer Therapeutics Consumption by Regions
- 4.1 Global Pet Cancer Therapeutics Consumption by Regions
- 4.2 North America Pet Cancer Therapeutics Consumption (2014-2019)
- 4.3 Europe Pet Cancer Therapeutics Consumption (2014-2019)
- 4.4 China Pet Cancer Therapeutics Consumption (2014-2019)
- 4.5 Japan Pet Cancer Therapeutics Consumption (2014-2019)
5 Global Pet Cancer Therapeutics Production, Revenue, Price Trend by Type
- 5.1 Global Pet Cancer Therapeutics Production Market Share by Type (2014-2019)
- 5.2 Global Pet Cancer Therapeutics Revenue Market Share by Type (2014-2019)
- 5.3 Global Pet Cancer Therapeutics Price by Type (2014-2019)
- 5.4 Global Pet Cancer Therapeutics Production Growth by Type (2014-2019)
6 Global Pet Cancer Therapeutics Market Analysis by Applications
- 6.1 Global Pet Cancer Therapeutics Consumption Market Share by Application (2014-2019)
- 6.2 Global Pet Cancer Therapeutics Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Pet Cancer Therapeutics Business
- 7.1 Aratana Therapeutics, Inc
- 7.1.1 Aratana Therapeutics, Inc Pet Cancer Therapeutics Production Sites and Area Served
- 7.1.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.1.3 Aratana Therapeutics, Inc Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 AB Science
- 7.2.1 AB Science Pet Cancer Therapeutics Production Sites and Area Served
- 7.2.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.2.3 AB Science Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Boehringer Ingelheim International GmbH
- 7.3.1 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Production Sites and Area Served
- 7.3.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.3.3 Boehringer Ingelheim International GmbH Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Zenoaq
- 7.4.1 Zenoaq Pet Cancer Therapeutics Production Sites and Area Served
- 7.4.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.4.3 Zenoaq Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Morphogenesis, Inc
- 7.5.1 Morphogenesis, Inc Pet Cancer Therapeutics Production Sites and Area Served
- 7.5.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.5.3 Morphogenesis, Inc Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 VetDC, Inc
- 7.6.1 VetDC, Inc Pet Cancer Therapeutics Production Sites and Area Served
- 7.6.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.6.3 VetDC, Inc Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 Karyopharm Therapeutics, Inc
- 7.7.1 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Production Sites and Area Served
- 7.7.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.7.3 Karyopharm Therapeutics, Inc Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Rhizen Pharmaceutical SA
- 7.8.1 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Production Sites and Area Served
- 7.8.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.8.3 Rhizen Pharmaceutical SA Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Regeneus Ltd.
- 7.9.1 Regeneus Ltd. Pet Cancer Therapeutics Production Sites and Area Served
- 7.9.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.9.3 Regeneus Ltd. Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Oasmia Pharmaceuticals AB
- 7.10.1 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Production Sites and Area Served
- 7.10.2 Pet Cancer Therapeutics Product Introduction, Application and Specification
- 7.10.3 Oasmia Pharmaceuticals AB Pet Cancer Therapeutics Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Zoetis
8 Pet Cancer Therapeutics Manufacturing Cost Analysis
- 8.1 Pet Cancer Therapeutics Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Pet Cancer Therapeutics
- 8.4 Pet Cancer Therapeutics Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Pet Cancer Therapeutics Distributors List
- 9.3 Pet Cancer Therapeutics Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Pet Cancer Therapeutics Market Forecast
- 11.1 Global Pet Cancer Therapeutics Production, Revenue Forecast
- 11.1.1 Global Pet Cancer Therapeutics Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Pet Cancer Therapeutics Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Pet Cancer Therapeutics Price and Trend Forecast (2019-2025)
- 11.2 Global Pet Cancer Therapeutics Production Forecast by Regions (2019-2025)
- 11.2.1 North America Pet Cancer Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Pet Cancer Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.3 China Pet Cancer Therapeutics Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Pet Cancer Therapeutics Production, Revenue Forecast (2019-2025)
- 11.3 Global Pet Cancer Therapeutics Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Pet Cancer Therapeutics Consumption Forecast (2019-2025)
- 11.3.2 Europe Pet Cancer Therapeutics Consumption Forecast (2019-2025)
- 11.3.3 China Pet Cancer Therapeutics Consumption Forecast (2019-2025)
- 11.3.4 Japan Pet Cancer Therapeutics Consumption Forecast (2019-2025)
- 11.4 Global Pet Cancer Therapeutics Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Pet Cancer Therapeutics Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
Summary:
Get latest Market Research Reports on Pet Cancer Therapeutics . Industry analysis & Market Report on Pet Cancer Therapeutics is a syndicated market report, published as Global Pet Cancer Therapeutics Market Research Report 2019. It is complete Research Study and Industry Analysis of Pet Cancer Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
